Sofinnova's eleventh flagship capital fund, reported as Europe's largest VC fund close of 2025. Its final close was reported at €650m on 17 Nov 2025. The mandate covers Europe and selected global markets. The stated stage focus is Early Stage, with emphasis on Health & Life Sciences.

At a glance

ManagerSofinnova Partners
Close statusFinal close
Capital€650m
Reported on17 Nov 2025
Fund typeVenture

Source and review

This fund record was manually reviewed on by the EverythingVC editorial team under our research methodology.

The capital figure reflects commitments reported by the cited source. It is not an estimate of remaining dry powder or current fundraising availability.